Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America”

3,063 pharma patents match "The United States of America" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 3,063
Index total 30,257
Page 12 / 128

Quick answer

This filtered view shows 3,063 pharmaceutical patents matching "The United States of America" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

3,063 results for “The United States of America” · 30,257 patents in full index Clear search

  1. US 11426415

    Treatment for Wolfram syndrome and other endoplasmic reticulum stress disorders

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 30, 2022 · Expires Aug 25, 2042

    granted

  2. US 11407818

    Antibodies that bind to dengue virus serotype 4 (DENV4) and methods of making and using the same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted

  3. US 11400150

    Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted

  4. US 11401503

    Methods of growing tumor infiltrating lymphocytes in gas-permeable containers

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted

  5. US 11389480

    Human monoclonal antibody targeting TNFR2 for cancer immunotherapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 19, 2022 · Expires Jul 14, 2042

    granted

  6. US 11390683

    Anti-mesothelin polypeptides and proteins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 19, 2022 · Expires Jul 14, 2042

    granted

  7. US 11389415

    Methods of regulating cannabinoid receptor activity-related disorders and diseases

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 19, 2022 · Expires Jul 14, 2042

    granted

  8. US 11384139

    Antibody targeting cell surface deposited complement protein C3d and use thereof

    THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services · Granted Jul 12, 2022 · Expires Jul 7, 2042

    granted

  9. US 11376318

    Methods of preparing anti-human papillomavirus antigen t cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 5, 2022 · Expires Jun 30, 2042

    granted

  10. US 11377660

    Chimeric antigen receptors targeting B-cell maturation antigen

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 5, 2022 · Expires Jun 30, 2042

    granted

  11. US 11370828

    Anti-coronavirus antibodies and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Svcs. · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted

  12. US 11369674

    Treatment method utilizing chikungunya virus (CHIKV) virus-like particles (VLPS) comprising the C, E2 and E1 structural proteins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted

  13. US 11369675

    Broadly protective inactivated influenza virus vaccine

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted

  14. US 11371024

    Attenuation of human respiratory syncytial virus by genome scale codon-pair deoptimization

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted

  15. US 11365195

    Atypical inhibitors of monoamine transporters; method of making; and use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 21, 2022 · Expires Jun 16, 2042

    granted

  16. US 11364298

    Photosensitizing antibody-fluorophore conjugates

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 21, 2022 · Expires Jun 16, 2042

    granted

  17. US 11364297

    Photosensitizing antibody-fluorophore conjugates

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 21, 2022 · Expires Jun 16, 2042

    granted

  18. US 11357839

    Brachyury protein, non-poxvirus non-yeast vectors encoding Brachyury protein, and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 14, 2022 · Expires Jun 9, 2042

    granted

  19. US 11359204

    Chimeric antigen receptors targeting B-cell maturation antigen

    THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services · Granted Jun 14, 2022 · Expires Jun 9, 2042

    granted

  20. US 11352435

    Anti-CD133 monoclonal antibodies and related compositions and methods

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted

  21. US 11351185

    Use of isovalerylspiramycins as anti-cancer agents to inhibit metastasis

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted

  22. US 11352365

    Biased potent opioid-like agonists as improved medications to treat chronic and acute pain and methods of using the same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted

  23. US 11352410

    Anti-KK-LC-1 T cell receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted

  24. US 11344615

    Nucleic acids encoding chimeric dengue/Zika viruses optimized for growth and stability in vero cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 31, 2022 · Expires May 26, 2042

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.